A citation-based method for searching scientific literature

D C Javitt, S R Zukin. Am J Psychiatry 1991
Times Cited: 2316







List of co-cited articles
1067 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
39

Glutamate receptor dysfunction and schizophrenia.
J W Olney, N B Farber. Arch Gen Psychiatry 1995
16


NMDA receptor hypofunction model of schizophrenia.
J W Olney, J W Newcomer, N B Farber. J Psychiatr Res 1999
699
12

Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Kate Merritt, Alice Egerton, Matthew J Kempton, Matthew J Taylor, Philip K McGuire. JAMA Psychiatry 2016
195
11


Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE).
A Egerton, B V Broberg, N Van Haren, K Merritt, G J Barker, D J Lythgoe, R Perez-Iglesias, L Baandrup, S W Düring, K V Sendt,[...]. Mol Psychiatry 2018
62
16

Glutamate and dopamine in schizophrenia: an update for the 21st century.
Oliver Howes, Rob McCutcheon, James Stone. J Psychopharmacol 2015
362
10




Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
A K Malhotra, D A Pinals, C M Adler, I Elman, A Clifton, D Pickar, A Breier. Neuropsychopharmacology 1997
491
9

Animal models of schizophrenia.
C A Jones, D J G Watson, K C F Fone. Br J Pharmacol 2011
412
9

The positive and negative syndrome scale (PANSS) for schizophrenia.
S R Kay, A Fiszbein, L A Opler. Schizophr Bull 1987
9


Effects of ketamine in normal and schizophrenic volunteers.
A C Lahti, M A Weiler, B A Tamara Michaelidis, A Parwani, C A Tamminga. Neuropsychopharmacology 2001
438
9

Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology.
J M Stone, C Dietrich, R Edden, M A Mehta, S De Simoni, L J Reed, J H Krystal, D Nutt, G J Barker. Mol Psychiatry 2012
178
8

Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.
Scott A Schobel, Nashid H Chaudhury, Usman A Khan, Beatriz Paniagua, Martin A Styner, Iris Asllani, Benjamin P Inbar, Cheryl M Corcoran, Jeffrey A Lieberman, Holly Moore,[...]. Neuron 2013
298
8

Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.
Juan E Belforte, Veronika Zsiros, Elyse R Sklar, Zhihong Jiang, Gu Yu, Yuqing Li, Elizabeth M Quinlan, Kazu Nakazawa. Nat Neurosci 2010
532
8


Subanesthetic doses of ketamine stimulate psychosis in schizophrenia.
A C Lahti, B Koffel, D LaPorte, C A Tamminga. Neuropsychopharmacology 1995
643
8

The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.
Wei Hu, Matthew L MacDonald, Daniel E Elswick, Robert A Sweet. Ann N Y Acad Sci 2015
124
8

Glutamate hypothesis in schizophrenia.
Yota Uno, Joseph T Coyle. Psychiatry Clin Neurosci 2019
81
9


Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
John E Lisman, Joseph T Coyle, Robert W Green, Daniel C Javitt, Francine M Benes, Stephan Heckers, Anthony A Grace. Trends Neurosci 2008
704
7

A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior.
M Carlén, K Meletis, J H Siegle, J A Cardin, K Futai, D Vierling-Claassen, C Rühlmann, S R Jones, K Deisseroth, M Sheng,[...]. Mol Psychiatry 2012
397
7



Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.
Arsime Demjaha, Alice Egerton, Robin M Murray, Shitij Kapur, Oliver D Howes, James M Stone, Philip K McGuire. Biol Psychiatry 2014
184
7

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.
Elias Mouchlianitis, Michael A P Bloomfield, Vincent Law, Katherine Beck, Sudhakar Selvaraj, Naresh Rasquinha, Adam Waldman, Federico E Turkheimer, Alice Egerton, James Stone,[...]. Schizophr Bull 2016
97
7


NMDA receptor and schizophrenia: a brief history.
Joseph T Coyle. Schizophr Bull 2012
250
7


D-serine added to antipsychotics for the treatment of schizophrenia.
G Tsai, P Yang, L C Chung, N Lange, J T Coyle. Biol Psychiatry 1998
500
7

Schizophrenia-An Overview.
Robert A McCutcheon, Tiago Reis Marques, Oliver D Howes. JAMA Psychiatry 2020
87
8

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.
Robert A McCutcheon, John H Krystal, Oliver D Howes. World Psychiatry 2020
72
9

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Josep Dalmau, Amy J Gleichman, Ethan G Hughes, Jeffrey E Rossi, Xiaoyu Peng, Meizan Lai, Scott K Dessain, Myrna R Rosenfeld, Rita Balice-Gordon, David R Lynch. Lancet Neurol 2008
6

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.
G Kirov, A J Pocklington, P Holmans, D Ivanov, M Ikeda, D Ruderfer, J Moran, K Chambert, D Toncheva, L Georgieva,[...]. Mol Psychiatry 2012
525
6


Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies.
Alice Egerton, Akarmi Bhachu, Kate Merritt, Grant McQueen, Agata Szulc, Philip McGuire. Front Psychiatry 2017
38
15

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.
J A Lieberman, R R Girgis, G Brucato, H Moore, F Provenzano, L Kegeles, D Javitt, J Kantrowitz, M M Wall, C M Corcoran,[...]. Mol Psychiatry 2018
114
6

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
Daniel C Javitt, Cameron S Carter, John H Krystal, Joshua T Kantrowitz, Ragy R Girgis, Lawrence S Kegeles, John D Ragland, Richard J Maddock, Tyler A Lesh, Costin Tanase,[...]. JAMA Psychiatry 2018
51
11

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia.
David A Lewis, Allison A Curley, Jill R Glausier, David W Volk. Trends Neurosci 2012
646
6

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
546
6

Assessing Brain Metabolism With 7-T Proton Magnetic Resonance Spectroscopy in Patients With First-Episode Psychosis.
Anna M Wang, Subechhya Pradhan, Jennifer M Coughlin, Aditi Trivedi, Samantha L DuBois, Jeffrey L Crawford, Thomas W Sedlak, Fredrick C Nucifora, Gerald Nestadt, Leslie G Nucifora,[...]. JAMA Psychiatry 2019
57
10

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies.
Patrick F Sullivan, Kenneth S Kendler, Michael C Neale. Arch Gen Psychiatry 2003
6

Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
Eline M P Poels, Lawrence S Kegeles, Joshua T Kantrowitz, Daniel C Javitt, Jeffrey A Lieberman, Anissa Abi-Dargham, Ragy R Girgis. Schizophr Res 2014
107
6

GABAergic interneuron origin of schizophrenia pathophysiology.
Kazu Nakazawa, Veronika Zsiros, Zhihong Jiang, Kazuhito Nakao, Stefan Kolata, Shuqin Zhang, Juan E Belforte. Neuropharmacology 2012
295
6

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Hsien-Yuan Lane, Yue-Cune Chang, Yi-Ching Liu, Chih-Chiang Chiu, Guochuan E Tsai. Arch Gen Psychiatry 2005
208
6

De novo mutations in schizophrenia implicate synaptic networks.
Menachem Fromer, Andrew J Pocklington, David H Kavanagh, Hywel J Williams, Sarah Dwyer, Padhraig Gormley, Lyudmila Georgieva, Elliott Rees, Priit Palta, Douglas M Ruderfer,[...]. Nature 2014
998
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.